Seeing Is Believing
TherapeuticsMD's activity chart (see below) currently has 23 price targets and 40 ratings on display.
Analysts average stock forecasts to be materialized ratio is 18.45% with an average time for these price targets to be met of 106.64 days.
Most recent stock forecast was given by from SCOTIABANK on 17-Aug-2023. First documented stock forecast 21-Sep-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 17-May-2022
$5
$2.89 (136.97%)
2 years 10 months 27 days ago
(17-Aug-2023)
7/8 (87.5%)
$1.35 (36.99%)
684
Buy Since 17-Oct-2019
$10
$7.9 (376.19%)
$125
4 years 1 months 7 days ago
(07-Jun-2022)
1/3 (33.33%)
$0.07 (0.70%)
28
Buy Since 10-Apr-2017
4 years 11 months 9 days ago
(05-Aug-2021)
0/1 (0%)
$340 (109.68%)
Buy Since 10-Oct-2016
5 years 2 months 8 days ago
(06-May-2021)
0/2 (0%)
$708 (498.59%)
Buy Since 04-Apr-2016
5 years 3 months 7 days ago
(07-Apr-2021)
0/8 (0%)
$202 (67.79%)
What is TXMD (TherapeuticsMD) average time for price targets to be met?
Which analyst has the current highest performing score on TXMD (TherapeuticsMD) with a proven track record?
Which analyst has the most public recommendations on TXMD (TherapeuticsMD)?
Which analyst is the currently most bullish on TXMD (TherapeuticsMD)?
Which analyst is the currently most reserved on TXMD (TherapeuticsMD)?